---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-116995"
form_type: "8-K"
ticker: "ANVS"
cik: "0001477845"
company_name: "Annovis Bio, Inc."
filed_at: "2026-10-19T23:49:30+00:00"
generated_at: "2026-10-20T10:05:45.273781+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Annovis Bio corrects proxy typo, restates Ernst & Young audit fees at $415,000 for 2025

## Summary
- Correction fixes a typographical error in the audit-fee disclosure in the proxy statement for the annual meeting held June 17, 2026.
- 2025 Ernst & Young fees: audit $415,000, audit-related $100,000, total $515,000.
- 2024 Ernst & Young fees: audit $375,000, audit-related $107,045, total $482,045.
- No tax fees or all-other fees were reported in either 2025 or 2024; no change of auditor disclosed.

## SEC filing metadata
- accession: 0001104659-26-116995
- form_type: 8-K
- ticker: ANVS
- cik: 0001477845
- company_name: Annovis Bio, Inc.
- filed_at: 2026-10-19T23:49:30+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1477845/000110465926116995/0001104659-26-116995-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1477845/000110465926116995/tm2627875d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-116995
- JSON: https://secwatch.observer/filing/0001104659-26-116995.json
- Plain text: https://secwatch.observer/filing/0001104659-26-116995.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.